Opus Point Partners Management’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $973K | Buy |
|
|||||
|
2019
Q2 | $1.3M | Hold |
|
|||||
|
2019
Q1 | $1.34M | Sell |
|
|||||
|
2018
Q4 | $1.02M | Sell |
|
|||||
|
2018
Q3 | $1.79M | Sell |
|
|||||
|
2018
Q2 | $1.71M | Sell |
|
|||||
|
2018
Q1 | $1.54M | Buy |
|
|||||
|
2017
Q4 | $1.14M | Sell |
|
|||||
|
2017
Q3 | $1.61M | Buy |
|
|||||
|
2017
Q2 | $1.16M | Sell |
|
|||||
|
2017
Q1 | $2.27M | Sell |
|
|||||
|
2016
Q4 | $3.06M | Buy |
|
|||||
|
2016
Q3 | $3.01M | Buy |
|
|||||
|
2016
Q2 | $2.02M | Sell |
|
|||||
|
2016
Q1 | $3.54M | Sell |
|
|||||
|
2015
Q4 | $6.29M | Sell |
|
|||||
|
2015
Q3 | $5.16M | Buy |
|
|||||
|
2015
Q2 | $3.88M | Sell |
|
|||||
|
2015
Q1 | $3.82M | Buy |
|
|||||
|
2014
Q4 | $3.39M | Buy |
|